Search research articles
Contact Us
Filters
Showing results (1-10 of 55) with videos related to
Page
of 6
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology
|
December 2, 2009
Regulation of hypoxia-inducible genes by PGC-1 alpha
Jonathan Shoag, Zolt Arany
JAMA Oncology
|
May 7, 2026
Reassessing Treatment Outcomes Following Immune-Related Adverse Events
Stephen Rhodes, Jonathan Shoag
The Journal of Urology
|
January 11, 2023
National Adherence to Guidelines for Antimicrobial Prophylaxis for Patients Undergoing Radical Cystectomy. Reply
Megan Prunty, Jonathan Shoag
Urology
|
January 2, 2019
EDITORIAL COMMENT
Jonathan Shoag, Gilbert J Wise
The Journal of Urology
|
September 28, 2013
Relationship between C-reactive protein and kidney stone prevalence
Jonathan Shoag, Brian H Eisner
Asian Journal of Andrology
|
April 16, 2016
Clinical variability and molecular heterogeneity in prostate cancer
Jonathan Shoag, Christopher E Barbieri
International Journal of Radiation Oncology, Biology, Physics
|
February 25, 2026
Continuing the Focal Fallacy
Jonathan Shoag, Daniel E Spratt
European Urology
|
January 22, 2025
Re: Robert Huddart, Shaista Hafeez, Clare Griffin, et al. Dose-escalated Adaptive Radiotherapy for Bladder Cancer: Results of the Phase 2 RAIDER Randomized Controlled Trial. Eur Urol 2025;87:60-70
Laura E Davis, Adam Calaway, Jonathan Shoag
European Urology
|
May 13, 2026
Re: Kitamura et al. Active Surveillance Versus Intravesical Bacillus Calmette-Guérin for High-grade T1 Bladder Cancer with Negative Second Transurethral Resection (JCOG1019). Eur Urol 2026. In press. http://dx.doi.org/10.1016/j.eururo.2026.01.008
Spyridon P Basourakos, Jonathan Shoag, Adam Calaway
Frontiers in Immunology
|
September 13, 2021
The Role of C-Reactive Protein in Kidney, Bladder, and Prostate Cancers
Daniel O'Brian, Megan Prunty, Alexander Hill, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 55) with videos related to
Sort By:
Page
of 6
Arteriosclerosis, Thrombosis, and Vascular Biology
|
December 2, 2009
Regulation of hypoxia-inducible genes by PGC-1 alpha
Jonathan Shoag, Zolt Arany
JAMA Oncology
|
May 7, 2026
Reassessing Treatment Outcomes Following Immune-Related Adverse Events
Stephen Rhodes, Jonathan Shoag
The Journal of Urology
|
January 11, 2023
National Adherence to Guidelines for Antimicrobial Prophylaxis for Patients Undergoing Radical Cystectomy. Reply
Megan Prunty, Jonathan Shoag
Urology
|
January 2, 2019
EDITORIAL COMMENT
Jonathan Shoag, Gilbert J Wise
The Journal of Urology
|
September 28, 2013
Relationship between C-reactive protein and kidney stone prevalence
Jonathan Shoag, Brian H Eisner
Asian Journal of Andrology
|
April 16, 2016
Clinical variability and molecular heterogeneity in prostate cancer
Jonathan Shoag, Christopher E Barbieri
International Journal of Radiation Oncology, Biology, Physics
|
February 25, 2026
Continuing the Focal Fallacy
Jonathan Shoag, Daniel E Spratt
European Urology
|
January 22, 2025
Re: Robert Huddart, Shaista Hafeez, Clare Griffin, et al. Dose-escalated Adaptive Radiotherapy for Bladder Cancer: Results of the Phase 2 RAIDER Randomized Controlled Trial. Eur Urol 2025;87:60-70
Laura E Davis, Adam Calaway, Jonathan Shoag
European Urology
|
May 13, 2026
Re: Kitamura et al. Active Surveillance Versus Intravesical Bacillus Calmette-Guérin for High-grade T1 Bladder Cancer with Negative Second Transurethral Resection (JCOG1019). Eur Urol 2026. In press. http://dx.doi.org/10.1016/j.eururo.2026.01.008
Spyridon P Basourakos, Jonathan Shoag, Adam Calaway
Frontiers in Immunology
|
September 13, 2021
The Role of C-Reactive Protein in Kidney, Bladder, and Prostate Cancers
Daniel O'Brian, Megan Prunty, Alexander Hill, et al.
Page
of 6